Metraipolis › archive › dc_108644697aa2

First-line immunotherapy for advanced hepatocellular carcinoma: a network meta-analysis of randomized trials with overall and HBV/HCV-stratified efficacy and… — Europe PMC PMID:42220514

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42220514
DOI
10.3389/fimmu.2026.1693251
License (as archived)
solo-consultazione
Archived
2026-11-02T08:38:03.547Z
SHA-256 of the archived text
77d92b39a0776c23c94dedc1cae0fe1b1cdf40cde1d8d76f6efe727865908cbb
Stable URL of this page
https://metraipolis.com/documento/dc_108644697aa2

How to cite

First-line immunotherapy for advanced hepatocellular carcinoma: a network meta-analysis of randomized trials with overall and HBV/HCV-stratified efficacy and… — Europe PMC PMID:42220514 — Europe PMC (en), https://europepmc.org/article/MED/42220514 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_108644697aa2 (Metraipolis archive dc_108644697aa2, sha256 77d92b39a0776c23c94dedc1cae0fe1b1cdf40cde1d8d76f6efe727865908cbb)
BibTeX
@misc{dc108644697aa2,
  title = {First-line immunotherapy for advanced hepatocellular carcinoma: a network meta-analysis of randomized trials with overall and HBV/HCV-stratified efficacy and… — Europe PMC PMID:42220514},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42220514},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_108644697aa2; sha256 77d92b39a0776c23c94dedc1cae0fe1b1cdf40cde1d8d76f6efe727865908cbb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42220514. Agents can read the archived copy with the MCP tool read_document.